Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis

Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are recommended as first-line therapies for chronic hepatitis B (CHB) infection. Although both drugs reduce hepatocellular carcinoma (HCC) risk, their comparative effectiveness remains controversial. We aimed to determine whether TDF is superio...

Full description

Saved in:
Bibliographic Details
Published in:Clin Transl Gastroenterol
Main Authors: Cheung, Ka Shing, Mak, Lung Yi, Liu, Sze Hang, Cheng, Ho Ming, Seto, Wai Kay, Yuen, Man Fung, Lai, Ching Lung
Format: Artigo
Language:Inglês
Published: Wolters Kluwer 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7544163/
https://ncbi.nlm.nih.gov/pubmed/33031195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000236
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items